420 related articles for article (PubMed ID: 18547127)
1. Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.
Nakagawa A; Watanabe N; Omori IM; Barbui C; Cipriani A; McGuire H; Churchill R; Furukawa TA;
CNS Drugs; 2008; 22(7):587-602. PubMed ID: 18547127
[TBL] [Abstract][Full Text] [Related]
2. Milnacipran versus other antidepressive agents for depression.
Nakagawa A; Watanabe N; Omori IM; Barbui C; Cipriani A; McGuire H; Churchill R; Furukawa TA
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD006529. PubMed ID: 19588396
[TBL] [Abstract][Full Text] [Related]
3. Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.
Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA;
CNS Drugs; 2010 Jan; 24(1):35-53. PubMed ID: 20030418
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine versus other anti-depressive agents for depression.
Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
[TBL] [Abstract][Full Text] [Related]
5. Antidepressants versus placebo for depression in primary care.
Arroll B; Elley CR; Fishman T; Goodyear-Smith FA; Kenealy T; Blashki G; Kerse N; Macgillivray S
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007954. PubMed ID: 19588448
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of clinical trials comparing milnacipran, a serotonin--norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder.
Papakostas GI; Fava M
Eur Neuropsychopharmacol; 2007 Jan; 17(1):32-6. PubMed ID: 16762534
[TBL] [Abstract][Full Text] [Related]
7. Milnacipran and selective serotonin reuptake inhibitors in major depression.
Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
[TBL] [Abstract][Full Text] [Related]
8. Sertraline versus other antidepressive agents for depression.
Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C
Cochrane Database Syst Rev; 2010 Apr; (4):CD006117. PubMed ID: 20393946
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine versus other types of pharmacotherapy for depression.
Cipriani A; Brambilla P; Furukawa T; Geddes J; Gregis M; Hotopf M; Malvini L; Barbui C
Cochrane Database Syst Rev; 2005 Oct; (4):CD004185. PubMed ID: 16235353
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.
Kasper S; Pletan Y; Solles A; Tournoux A
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():35-9. PubMed ID: 8923125
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of milnacipran: an overview.
Montgomery SA; Prost JF; Solles A; Briley M
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():47-51. PubMed ID: 8923127
[TBL] [Abstract][Full Text] [Related]
12. Sertraline versus other antidepressive agents for depression.
Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C
Cochrane Database Syst Rev; 2010 Jan; (1):CD006117. PubMed ID: 20091586
[TBL] [Abstract][Full Text] [Related]
13. Sertraline versus other antidepressive agents for depression.
Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C
Cochrane Database Syst Rev; 2009 Apr; (2):CD006117. PubMed ID: 19370626
[TBL] [Abstract][Full Text] [Related]
14. Antidepressants for depressed elderly.
Mottram P; Wilson K; Strobl J
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD003491. PubMed ID: 16437456
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
[TBL] [Abstract][Full Text] [Related]
16. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability.
Puech A; Montgomery SA; Prost JF; Solles A; Briley M
Int Clin Psychopharmacol; 1997 Mar; 12(2):99-108. PubMed ID: 9219045
[TBL] [Abstract][Full Text] [Related]
17. Citalopram versus other anti-depressive agents for depression.
Cipriani A; Purgato M; Furukawa TA; Trespidi C; Imperadore G; Signoretti A; Churchill R; Watanabe N; Barbui C
Cochrane Database Syst Rev; 2012 Jul; 7(7):CD006534. PubMed ID: 22786497
[TBL] [Abstract][Full Text] [Related]
18. Fluvoxamine versus other anti-depressive agents for depression.
Omori IM; Watanabe N; Nakagawa A; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA
Cochrane Database Syst Rev; 2010 Mar; (3):CD006114. PubMed ID: 20238342
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
Leinonen E; Lepola U; Koponen H; Mehtonen OP; Rimon R
Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348
[TBL] [Abstract][Full Text] [Related]
20. The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis.
Häuser W; Wolfe F; Tölle T; Uçeyler N; Sommer C
CNS Drugs; 2012 Apr; 26(4):297-307. PubMed ID: 22452526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]